[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-338561-105":59,"doc-detail-338561-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","breast-cancers-that-disseminate-to-bone-marrow-acquire-aggressive-phenotypes-through-cx43-related-tumor-stroma-tunnels-research-article","Breast cancers that disseminate to bone marrow acquire aggressive phenotypes through CX43-related tumor-stroma tunnels - Research article","","Estrogen receptor-positive breast cancer frequently spreads to bone marrow, where mesenchymal stromal cells (MSCs) influence disease course. Tumor–MSC co-cultures were modeled and integrated transcriptome–proteome network analyses used to map contact-induced changes. Conditioned media from MSCs did not reproduce the full gene/protein program, revealing both borrowed and tumor-intrinsic components. Protein interaction networks prioritized the borrowed factor CCDC88A/GIV. MSCs transferred GIV via connexin 43–facilitated tunneling nanotubes, reinstating GIV in GIV-negative cells recapitulated ~20% of induction patterns, increased antiestrogen resistance, and enhanced dissemination.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/breast-cancers-that-disseminate-to-bone-marrow-acquire-aggressive-phenotypes-through-cx43-related-tumor-stroma-tunnels-research-article/338561/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/breast-cancers-that-disseminate-to-bone-marrow-acquire-aggressive-phenotypes-through-cx43-related-tumor-stroma-tunnels-research-article/338561.png","ImageObject",300,407,{"name":92,"@type":93},"Genevieve","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What role do mesenchymal stromal cells play in ER+ breast cancer bone marrow dissemination?","Question",{"text":112,"@type":113},"MSCs interact with ER+ tumor cells in the bone marrow niche and shape disease trajectory by promoting more aggressive phenotypes and contact-dependent molecular changes.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Why didn’t MSC-conditioned media reproduce the same effects as direct co-culture?",{"text":117,"@type":113},"Conditioned media failed to recapitulate the genes and proteins induced by direct contact, indicating that physical intercellular transfer is required for part of the response.",{"name":119,"@type":110,"acceptedAnswer":120},"How do MSCs deliver the key factor CCDC88A/GIV to ER+ breast cancer cells?",{"text":121,"@type":113},"MSCs transfer GIV protein through tunneling nanotubes, with intercellular transport facilitated by connexin (Cx)43.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},338561,1790916120,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1374391974585,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","The Journal of Clinical Investigation RESEAR CH ARTICLE  \nBreast cancers that disseminate to bone marrow acquire aggressive phenotypes through CX43-related tumor-stroma tunnels  \nSaptarshi Sinha,1 Brennan W. Callow,2 Alex P. Farfel,2 Suchismita Roy,1 Siyi Chen,2 Maria Masotti,3 Shrila Rajendran,2 Johanna M. Buschhaus,2,4 Celia R. Espinoza,1 Kathryn E. Luker,2,5 Pradipta Ghosh,1,6,7,8 and Gary D. Luker2,4,5  \n1Department of Cellular and Molecular Medicine, School of Medicine, UCSD, La Jolla, California, USA. 2Center for Molecular Imaging, Department of Radiology, 3Biostatistics, School of Public Health, 4Department of Biomedical Engineering, and 5Biointerfaces Institute, University of Michigan, Ann Arbor, Michigan, USA. 6Moores Comprehensive Cancer Center, 7Department of Medicine, 8School of Medicine, and Veterans Affairs Medical Center, UCSD, La Jolla, California, USA.  \nEstrogen receptor-positive (ER+) breast cancer commonly disseminatesto bone marrow, where interactions with mesenchymal stromal cells (MSCs) shape disease trajectory. We modeled these interactions with tumor-MSC co-cultures and used an integrated transcriptome-proteome-network-analyses workflow to identify a comprehensive catalog of contactinduced changes. Conditioned media from MSCs failed to recapitulate genes and proteins, some borrowed and others tumor-intrinsic, induced in cancer cells by direct contact. Protein-protein interaction networks revealed the rich connectome between “borrowed” and “intrinsic” components. Bioinformatics prioritized one of the borrowed components, CCDC88A/GIV, a multi-modular metastasis-related protein that has recently been implicated in driving a hallmark of cancer, growth signaling autonomy. MSCs transferred GIV protein to ER+ breast cancer cells (that lack GIV) through tunnelling nanotubes via connexin (Cx)43-facilitated intercellular transport. Reinstating GIV alone in GIV-negative breast cancer cells reproduced approximately 20% of both the borrowed and the intrinsic gene induction patterns from contact co-cultures; conferred resistance to antiestrogen drugs; and enhanced tumor dissemination. Findings provide a multiomic insight into MSC→tumor cell intercellular transport and validate how transport of one such candidate, GIV, from the haves (MSCs) to have-nots (ER+ breast cancer) orchestrates aggressive disease states.  \nIntroduction  \nEstrogen receptor-positive (ER+) breast cancer, the most common subtype, preferentially disseminates to bone and bone marrow (1, 2). Bone metastases remain incurable and cause debilitating symptoms, e.g., pain, fractures, and life-threatening hypercalcemia (3). Bone marrow harbors disseminated tumor cells (DTCs) in breast cancer. DTCs may persist in a clinically occult state for decades before proliferating and potentially traveling to other organs to produce delayed recurrences in approximately 40% of patients with ER+ breast cancer (4). Recurrent disease is more aggressive, relatively resistant to treatment, and currently incurable. Little progress has been made in treating breast cancer that has already disseminated to bone (5), largely because we lack a comprehensive understanding of molecular mechanisms that make ER+ breast cancer cells more aggressive in the bone marrow niche (6).  \nInteractions with stromal cells in the bone marrow environment are proposed to shape key functions of breast cancer cells  \nConflict of interest: GDL has received research materials from Spexis. All other authors declare no competing interests.  \nCopyright: © 2024, Sinha et al. This is an open access article published under the terms of the Creative Commons Attribution 4.0 International License.  \nSubmitted: March 29, 2023; Accepted: October 24, 2024; Published: October 31, 2024.  \nReference information: J Clin Invest. 2024;134(24):e170953 .  \n[https://doi.org/10.1172/JCI170953](https://doi.org/10.1172/JCI170953) .  \nthat determine disease progression and outcomes (7). Mesenchymal stem cells (MSCs), a multip","cbCaidpO3zrcrFy0","https://ap.wps.com/l/cbCaidpO3zrcrFy0","pdf",13480260,17,"English","# Introduction\n## Stromal interactions and disease progression\n## Intercellular communication channels (gap junctions and tunneling nanotubes)\n## Knowledge gap and study approach","[{\"question\":\"What role do mesenchymal stromal cells play in ER+ breast cancer bone marrow dissemination?\",\"answer\":\"MSCs interact with ER+ tumor cells in the bone marrow niche and shape disease trajectory by promoting more aggressive phenotypes and contact-dependent molecular changes.\"},{\"question\":\"Why didn’t MSC-conditioned media reproduce the same effects as direct co-culture?\",\"answer\":\"Conditioned media failed to recapitulate the genes and proteins induced by direct contact, indicating that physical intercellular transfer is required for part of the response.\"},{\"question\":\"How do MSCs deliver the key factor CCDC88A/GIV to ER+ breast cancer cells?\",\"answer\":\"MSCs transfer GIV protein through tunneling nanotubes, with intercellular transport facilitated by connexin (Cx)43.\"}]","Breast cancers that disseminate to bone marrow acquire aggressive phenotypes through CX43-related tumor-stroma tunnels - Research article | PDF",1790024255,43,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fd5a87a1ee042bd9d2a76ceeca0f8af5.webp",983,1315,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/57b651ea47d5cb4207d1aace8d038a9f.webp",982,1314,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bf15a189e5cf85b52a5c306d1f997058.webp",981,1312,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/250fd4a1ec316c477e0afae87b545bf6.webp",980,1311]